MedPath

Validation process of liquid biopsy for solid tumors

Not Applicable
Conditions
Health Condition 1: D499- Neoplasm of unspecified behavior of unspecified site
Registration Number
CTRI/2023/03/050258
Lead Sponsor
Cancer Research and Statistic Foundation CRSF
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All cancer patients registered in Homi Bhabha Cancer Hospital & Research Center, Muzaffarpur

Exclusion Criteria

None

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Establishment of proper storage and preservation â?? BiorepositoryTimepoint: 5 years
Secondary Outcome Measures
NameTimeMethod
Analysis of sequenced result to come up with novel finding with translational impact.Timepoint: 5 year;Extraction of DNA/RNA from rare tumor samples, samples with specific requirements like metastatic or on progression cases.Timepoint: Every month;Monthly evaluation of total number of samples (in pair tissue and blood) collected/extracted.Timepoint: Every month
© Copyright 2025. All Rights Reserved by MedPath